All Stories

  1. The global importance of chronic obstructive pulmonary disease
  2. The predictive value of an adjusted COPD assessment test score on the risk of respiratory-related hospitalizations in severe COPD patients
  3. Comparison of the Dyspnoea-12 and Multidimensional Dyspnoea Profile in people with COPD
  4. Assessing knowledge, adherence and barriers to implement COPD guidelines in COPD care in Saudi Arabia
  5. Differences in patient characteristics and associations with comorbid load in Dutch and Australian COPD patients
  6. Heliox moderates multidimensional domains of exertional dyspnoea in people with COPD
  7. LATE-BREAKING ABSTRACT: Self-management interventions that include COPD exacerbation action plans improve health-related quality of life – A Cochrane review
  8. Barriers for setting up a pulmonary rehabilitation program in the Eastern Province of Saudi Arabia
  9. Clinical Practice Guideline on Adult Domiciliary Oxygen Therapy: Executive summary from the Thoracic Society of Australia and New Zealand
  10. Current care services provided for patients with COPD in the Eastern province in Saudi Arabia: a descriptive study
  11. Validation of the 12-item partners in health scale to measure patient self-management behaviour and knowledge in Dutch patients with COPD
  12. Cognitive Behavioral Therapy for Management of Dyspnea: A Pilot Study
  13. Self management interventions including action plans for exacerbations versus usual care in people with chronic obstructive pulmonary disease
  14. Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN study—a randomised controlled trial
  15. Self management for patients with chronic obstructive pulmonary disease
  16. Education in COPD self‐management: only part of the game
  17. A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: The COPE-III study protocol
  18. Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study
  19. Barriers to, and facilitators for, referral to pulmonary rehabilitation in COPD patients from the perspective of Australian general practitioners: a qualitative study
  20. Frequency of referral to and attendance at a pulmonary rehabilitation program amongst patients admitted to a tertiary hospital with chronic obstructive pulmonary disease
  21. Health literacy
  22. Management of depression and anxiety in COPD
  23. Feasibility of omega-3 fatty acid supplementation as an adjunct therapy for people with chronic obstructive pulmonary disease: study protocol for a randomized controlled trial
  24. Which chronic obstructive pulmonary disease care recommendations have low implementation and why? A pilot study
  25. Use of an Australian Quality of Life Tool in Patients with COPD
  26. A Reduction in the Use of Volunteered Descriptors of Air Hunger Is Associated With Increased Walking Distance in People With COPD
  27. Fatigue in COPD: association with functional status and hospitalisations
  28. Treatments for anxiety and depression in patients with chronic obstructive pulmonary disease: A literature review
  29. Why are some evidence-based care recommendations in chronic obstructive pulmonary disease better implemented than others? Perspectives of medical practitioners
  30. Once-Daily Opioids for Chronic Dyspnea: A Dose Increment and Pharmacovigilance Study
  31. Health, economic, psychological and social impact of educating carers of patients with advanced pulmonary disease (protocol)
  32. Continuous Monitoring of Circadian Glycemic Patterns In Patients Receiving Prednisolone For COPD
  33. Simplified COPD screening: validation of the PiKo-6® in primary care
  34. Influence of Acute Oxygen Therapy on Maximal Exercise in Chronic Heart Failure
  35. Influence of Oxygen on Ergoreflex and Cardiovascular Parameters in Chronic Heart Failure
  36. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial
  37. Affective Descriptors of the Sensation of Breathlessness Are More Highly Associated With Severity of Impairment Than Physical Descriptors in People With COPD
  38. Combination therapy with long-acting  -agonists plus inhaled corticosteroids is no more effective than LABA monotherapy for mortality outcomes and severe exacerbations in moderate to very severe COPD and is associated with serious adverse effects
  39. Heliox, dyspnoea and exercise in COPD
  40. Providing reviews of evidence to COPD patients: controlled prospective 12-month trial
  41. Quality of recalled dyspnoea is different from exerciseinduced dyspnoea: an experimental study
  42. A randomised trial of the Flinders Program to improve patient self-management competencies in a range of chronic conditions: study rationale and protocol
  43. The Language of Breathlessness Differentiates Between Patients With COPD and Age-Matched Adults
  44. Nutritional status and dietary intake of outpatients with chronic obstructive pulmonary disease
  45. Chronic obstructive pulmonary disease (COPD) is a major personal and public health burden in Australia
  46. Can We Predict Which Patients with Refractory Dyspnea Will Respond to Opioids?
  47. SA HealthPlus: A Controlled Trial of a Statewide Application of a Generic Model of Chronic Illness Care
  48. Providing patients with reviews of evidence about COPD treatments: a controlled trial of outcomes
  49. ABS49: Splitting COPD and asthma: Validation of the differential diagnosis questionnaire (DDQ) in Australian primary care
  50. Perceived Locus of Symptom Limitation during Constant Work Rate Cycle Ergometry in COPD Patients Treated with Tiotropium
  51. Hypoxia Suppresses Symptom Perception in Asthma
  52. Systematic assessment of clinical practice guidelines for the management of chronic obstructive pulmonary disease
  53. The sa healthplus coordinated care trial: Developing an outcomes based system of care. Psychiatric outcomes and implications for mental health services
  54. Fluvoxamine-Methadone Interaction
  55. A Comparison of Two Long-Acting Vasoselective Calcium Antagonists in Pulmonary Hypertension Secondary to COPD
  56. Comparison of Oral Bambuterol and Terbutaline in Elderly Patients with Chronic Reversible Airflow Obstruction
  57. Buspirone for the Treatment of Anxiety in Patients with Chronic Obstructive Airways Disease
  58. Near-fatal asthma in South Australia:descriptive features and medication use
  60. Characteristics of near-fatal asthma in childhood
  61. Psychiatric and medical features of near fatal asthma.
  62. A comparison of asthma deaths and near-fatal asthma attacks in South Australia
  63. Lung bleeding associated with kidney bleeding
  64. Near fatal asthma attacks: the reliability of descriptive information collected from close acquaintances.
  65. Felodipine Improves Pulmonary Hemodynamics in Chronic Obstructive Pulmonary Disease
  66. Effect of Exercise on Atrial Natriuretic Peptide (ANP) Levels in Patients with COPD
  67. Oxitropium Bromide
  68. Effects of Inhaled Oxitropium and Fenoterol, Alone and in Combination, in Chronic Airflow Obstruction
  69. Is Asthma a Psychosomatic Illness?
  70. Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliber
  71. Long-term stability of bronchial responsiveness to histamine.
  72. Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma.
  73. Inhibition of allergen-induced asthma by three forms of sodium cromoglycate
  74. Effects of oxatomide compared with chlorpheniramine in allergic rhinoconjunctivitis
  75. Bronchial responsiveness to inhaled histamine and exercise
  76. Selectivity of beta adrenoreceptor antagonist drugs assessed by histamine bronchial provocation
  77. Reproducibility and comparison of responses to inhaled histamine and methacholine.
  79. 157. Comparison of histamine with methacholine in a standardized inhalation challenge test
  80. Pneumonia in the Elderly